SearchDictionaryMobileLogin

First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.

AbstractOBJECTIVE: Restless legs syndrome (RLS) seems to improve immediately after a single dose of dopamine-agonists (DA). The aim of the present study was to investigate the acute effects of a low standard dose of pramipexole in RLS drug-naïve patients. METHODS: A single-blind placebo-controlled study in 32 consecutive idiopathic RLS de-novo patients was carried out. Patients who met the standard criteria for RLS, with a PLMS index greater than 10 as well as an RLS rating scale score greater than 20 underwent clinical and neurophysiological evaluation, hematological screening and two consecutive full-night polysomnographies. On the second night, all patients received 0.25mg of pramipexole or placebo at 9:00 p.m. Acute symptom response was assessed by a visual analogical scale (VAS). RESULTS: Eighteen patients received pramipexole and 14 patients received placebo. Compared to placebo, the single low dose (0.25mg) of pramipexole significantly improved RLS symptoms (VAS: from 7.4+/-1.68 to 1.3+/-1.62, p<0.00001) and strongly reduced PLMS index (from 45.8+/-33.56 to 9.4+/-11.40, p<0.0002). A significant increase in the percentage of stage 2 non-rapid eye movement (NREM) sleep was also observed in the pramipexole group (from 38.7+/-10.50 to 50.6+/-12.13, p<0.02). CONCLUSIONS: A low dose of pramipexole was effective in treatment-naïve patients with RLS from the first night of administration. These results support a direct involvement of the dopaminergic system in RLS pathogenesis and might have important implications for a possible future pramipexole administration on-demand, as well as for a pharmacological test to confirm diagnosis in clinically complex cases.
AuthorsMauro Manconi, Raffaele Ferri, Marco Zucconi, Alessandro Oldani, Maria Livia Fantini, Vincenza Castronovo, Luigi Ferini-Strambi (Affiliation: Sleep Disorders Center, Department of Neurology, Scientific Institute and University Ospedale San Raffaele, Vita-Salute University, Milan, Italy. manconi.mauro at hsr.it)
JournalSleep medicine (Sleep Med) Vol. 8 Issue 5 Pg. 491-7 (Aug 2007) ISSN: 1389-9457 Netherlands
PMID17512780 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Benzothiazoles
  • Dopamine Agonists
  • pramipexol
Topics
  • Adult
  • Aged
  • Benzothiazoles (administration & dosage)
  • Dopamine Agonists (administration & dosage)
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Male
  • Middle Aged
  • Polysomnography (methods)
  • Questionnaires
  • Restless Legs Syndrome (drug therapy)
  • Severity of Illness Index
  • Single-Blind Method
  • Sleep Stages (drug effects)
  • Treatment Outcome